Clinical Study

Impact of Previous ART and of ART Initiation on Outcome of HIV-Associated Tuberculosis

Table 2

Multivariable odds ratios* of unsuccessful outcome of tuberculosis treatment and death according to baseline characteristics for 246 HIV-infected patients with tuberculosis.

VariableUnsatisfactory outcome of TB treatmentDeath
OR (95% CI) valueOR (95% CI) value

Sex
 Male1.001.00
 Female0.38 (0.16–0.90)0.0290.35 (0.10–1.27)0.112
Place of origin
 Born in Italy1.001.00
 Foreign born3.66 (1.48–9.06)0.0051.98 (0.52–7.45)0.314
Age at TB diagnosis (years)
 <401.001.00
 ≥401.04 (0.52–2.11)0.9092.34 (0.94–5.84)0.068
Education (years)
 0–81.001.00
 9–181.00 (0.44–2.27)0.9960.81 (0.27–2.37)0.698
 Unknown0.83 (0.35–1.96)0.6710.69 (0.20–2.35)0.550
History of imprisonment
 Yes1.001.00
 No/unknown1.93 (0.65–5.74)0.2382.17 (0.53–8.90)0.282
Mode of HIV infection
 Injecting drug use1.001.00
 Other0.42 (0.19–0.93)0.0330.25 (0.08–0.74)0.012
Housing
 Private1.001.00
 Community/homeless2.21 (0.93–5.30)0.0740.44 (0.09–2.30)0.333
CD4 lymphocyte count (increase: 50 cells)0.96 (0.88–1.04)0.3260.83 (0.71–0.97)0.020
AIDS
 Yes1.001.00
 No0.90 (0.45–1.82)0.7780.44 (0.16–1.19)0.106
Site of diseases
 Pulmonary1.001.00
 Extra pulmonary0.66 (0.29–1.50)0.3201.15 (0.42–3.18)0.782
History of TB treatment
 New cases1.001.00
 Previously treated cases0.96 (0.39–2.36)0.9300.71 (0.22–2.32)0.572
Drug susceptibility test
 Susceptible TB1.001.00
 DR TB1.03 (0.33–3.21)0.9620.44 (0.07–2.69)0.376
 MDR TB0.83 (0.03–20.52)0.91137.10 (1.98–693.79)0.016
 Not available1.41 (0.71–2.78)0.3221.24 (0.50–3.07)0.649
Awareness of HIV seropositivity and HIV treatment history
 Not aware1.001.00
 Aware and cART naive5.11 (2.04–12.80)0.0012.95 (0.77–11.33)0.115
 Not cART naive3.31 (1.29–8.46)0.0134.04 (1.09–14.96)0.037
Concomitant diseases at TB diagnosis
 Yes1.001.00
 No1.38 (0.59–3.26)0.4610.59 (0.23–1.55)0.286

*From polytomous logistic regression model with successful outcome as reference category.